Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

The effect of fucoxanthin rich power on the lipid metabolism in rats with a high fat diet

  • Ha, Ae Wha (Department of Food Science and Nutrition, Dankook University) ;
  • Kim, Woo Kyoung (Department of Food Science and Nutrition, Dankook University)
  • Received : 2013.03.07
  • Accepted : 2013.05.14
  • Published : 2013.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study determined the effects of fucoxanthin on gene expressions related to lipid metabolism in rats with a high-fat diet. Rats were fed with normal fat diet (NF, 7% fat) group, high fat diet group (HF, 20% fat), and high fat with 0.2% fucoxanthin diet group (HF+Fxn) for 4 weeks. Body weight changes and lipid profiles in plasma, liver, and feces were determined. The mRNA expressions of transcriptional factors such as sterol regulatory element binding protein (SREBP)-1c, Carnitine palmitoyltransferase-1 (CPT1), Cholesterol $7{\alpha}$-hydroxylase1 (CYP7A1) as well as mRNA expression of several lipogenic enzymes were determined. Fucoxanthin supplements significantly increased plasma high density lipoprotein (HDL) concentration (P < 0.05). The hepatic total lipids, total cholesterols, and triglycerides were significantly decreased while the fecal excretions of total lipids, cholesterol, and triglycerides were significantly increased in HF+Fxn group (P < 0.05). The mRNA expression of hepatic Acetyl-CoA carboxylase (ACC), Fatty acid synthase (FAS), and Glucose-6-phosphate dehydrogenase (G6PDH) as well as SREBP-1C were significantly lower in HF+Fxn group compared to the HF group (P < 0.05). The hepatic mRNA expression of Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) and Acyl-CoA cholesterol acyltransferase (ACAT) were significantly low while lecithin-cholesterol acyltransferase (LCAT) was significantly high in the HF+Fxn group (P < 0.05). There was significant increase in mRNA expression of CPT1 and CYP7A1 in the HF+Fxn group, compared to the HF group (P < 0.05). In conclusion, consumption of fucoxanthin is thought to be effective in improving lipid and cholesterol metabolism in rats with a high fat diet.

Keywords

References

  1. Barres R, Zierath JR. DNA methylation in metabolic disorders. Am J Clin Nutr 2011;93:897S-900S. https://doi.org/10.3945/ajcn.110.001933
  2. Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005;16:421-7. https://doi.org/10.1097/01.mol.0000174153.53683.f2
  3. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005;42:44-52.
  4. MacArtain P, Gill CI, Brooks M, Campbell R, Rowland IR. Nutritional value of edible seaweeds. Nutr Rev 2007;65:535-43. https://doi.org/10.1111/j.1753-4887.2007.tb00278.x
  5. Chandini SK, Ganesan P, Suresh PV, Bhaskar N. Seaweeds as a source of nutritionally beneficial compounds - a review. J Food Sci Technol 2008;45:1-3.
  6. Maeda H, Hosokawa M, Sashima T, Funayama K, Miyashita K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem Biophys Res Commun 2005;332:392-7. https://doi.org/10.1016/j.bbrc.2005.05.002
  7. Miyashita K, Maeda H, Okada T, Abe M, Hosokawa M. Antiobesity and anti-diabetic effects of allenic carotenoid, fucoxanthin. Agro Food Ind Hi Tech 2010;21:24-7.
  8. Okada T, Nakai M, Maeda H, Hosokawa M, Sashima T, Miyashita K. Suppressive effect of neoxanthin on the differentiation of 3T3-L1 adipose cells. J Oleo Sci 2008;57:345-51. https://doi.org/10.5650/jos.57.345
  9. Yim MJ, Hosokawa M, Mizushina Y, Yoshida H, Saito Y, Miyashita K. Suppressive effects of amarouciaxanthin A on 3T3-L1 adipocyte differentiation through down-regulation of PPAR $\gamma$ and C/EBP$\alpha$ mRNA expression. J Agric Food Chem 2011;59: 1646-52. https://doi.org/10.1021/jf103290f
  10. Park HJ, Lee MK, Park YB, Shin YC, Choi MS. Beneficial effects of Undaria pinnatifida ethanol extract on diet-inducedinsulin resistance in C57BL/6J mice. Food Chem Toxicol 2011; 49:727-33. https://doi.org/10.1016/j.fct.2010.11.032
  11. Maeda H, Hosokawa M, Sashima T, Miyashita K. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. J Agric Food Chem 2007;55:7701-6. https://doi.org/10.1021/jf071569n
  12. Woo MN, Jeon SM, Shin YC, Lee MK, Kang MA, Choi MS. Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice. Mol Nutr Food Res 2009;53:1603-11. https://doi.org/10.1002/mnfr.200900079
  13. Jeon SM, Kim HJ, Woo MN, Lee MK, Shin YC, Park YB, Choi MS. Fucoxanthin-rich seaweed extract suppresses body weight gain and improves lipid metabolism in high-fat-fed C57BL/6J mice. Biotechnol J 2010;5:961-9. https://doi.org/10.1002/biot.201000215
  14. Maeda H, Hosokawa M, Sashima T, Murakami-Funayama K, Miyashita K. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol Med Rep 2009;2:897-902.
  15. Hu X, Li Y, Li C, Fu Y, Cai F, Chen Q, Li D. Combination of fucoxanthin and conjugated linoleic acid attenuates body weight gain and improves lipid metabolism in high-fat dietinduced obese rats. Arch Biochem Biophys 2012;519:59-65. https://doi.org/10.1016/j.abb.2012.01.011
  16. Woo MN, Jeon SM, Kim HJ, Lee MK, Shin SK, Shin YC, Park YB, Choi MS. Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice. Chem Biol Interact 2010;186: 316-22. https://doi.org/10.1016/j.cbi.2010.05.006
  17. Mayes PA. Biosynthesis of fatty acids. In: Murray RK, Harper HA, editors. Harper's Biochemistry. 25th ed. Stamford (CT): Appleton and Lange; 2000. p.230-57.
  18. Chen J, Zhao H, Ma X, Han X, Luo L, Wang L, Han J, Liu B, Wang W. The effects of jiang-zhi-ning and its main components on cholesterol metabolism. Evid Based Complement Alternat Med 2012;2012:928234.
  19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-8. https://doi.org/10.1006/meth.2001.1262
  20. Frings CS, Dunn RT. A colorimetric method for determination of total serum lipids based on the sulfo-phospho-vanillin reaction. Am J Clin Pathol 1970;53:89-91. https://doi.org/10.1093/ajcp/53.1.89
  21. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
  22. Bettzieche A, Brandsch C, Hirche F, Eder K, Stangl GI. L-cysteine down-regulates SREBP-1c-regulated lipogenic enzymes expression via glutathione in HepG2 cells. Ann Nutr Metab 2008;52:196-203. https://doi.org/10.1159/000138123
  23. Foretz M, Guichard C, Ferré P, Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A 1999;96:12737-42. https://doi.org/10.1073/pnas.96.22.12737
  24. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997;89:331-40. https://doi.org/10.1016/S0092-8674(00)80213-5
  25. Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL, Brown MS. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 1998;12:3182-94. https://doi.org/10.1101/gad.12.20.3182
  26. Diraison F, Dusserre E, Vidal H, Sothier M, Beylot M. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 2002;282:E46-51.
  27. Nicolle C, Cardinault N, Aprikian O, Busserolles J, Grolier P, Rock E, Demigné C, Mazur A, Scalbert A, Amouroux P, Rémésy C. Effect of carrot intake on cholesterol metabolism and on antioxidant status in cholesterol-fed rat. Eur J Nutr 2003;42: 254-61. https://doi.org/10.1007/s00394-003-0419-1
  28. Matsumoto M, Hosokawa M, Matsukawa N, Hagio M, Shinoki A, Nishimukai M, Miyashita K, Yajima T, Hara H. Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats. Eur J Nutr 2010;49:243-9. https://doi.org/10.1007/s00394-009-0078-y
  29. Siperstein MD. Regulation of cholesterol biosynthesis in normal and malignant tissues. Curr Top Cell Regul 1970;2:65-100.
  30. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 2002;110: 109-17. https://doi.org/10.1172/JCI0215387

Cited by

  1. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats vol.14, pp.1, 2015, https://doi.org/10.1186/s12944-015-0082-6
  2. Ethanol Extract of Peanut Sprout Lowers Blood Triglyceride Levels, Possibly Through a Pathway Involving SREBP-1c in Rats Fed a High-Fat Diet vol.18, pp.8, 2015, https://doi.org/10.1089/jmf.2014.3370
  3. Fucoxanthin: A Promising Medicinal and Nutritional Ingredient vol.2015, pp.1741-4288, 2015, https://doi.org/10.1155/2015/723515
  4. Fucoxanthin Enhances Chain Elongation and Desaturation of Alpha-Linolenic Acid in HepG2 Cells vol.50, pp.10, 2015, https://doi.org/10.1007/s11745-015-4059-z
  5. Cinnamon extract improves the body composition and attenuates lipogenic processes in the liver and adipose tissue of rats vol.6, pp.10, 2015, https://doi.org/10.1039/C5FO00569H
  6. Corn silk extract improves cholesterol metabolism in C57BL/6J mouse fed high-fat diets vol.10, pp.5, 2016, https://doi.org/10.4162/nrp.2016.10.5.501
  7. Antioxidant dietary approach in treatment of fatty liver: New insights and updates vol.23, pp.23, 2017, https://doi.org/10.3748/wjg.v23.i23.4146
  8. Phaeodactylum tricornutum in finishing diets for gilthead seabream: effects on skin pigmentation, sensory properties and nutritional value vol.29, pp.4, 2017, https://doi.org/10.1007/s10811-017-1125-3
  9. Undaria pinnatifida and Fucoxanthin Ameliorate Lipogenesis and Markers of Both Inflammation and Cardiovascular Dysfunction in an Animal Model of Diet-Induced Obesity vol.14, pp.8, 2016, https://doi.org/10.3390/md14080148
  10. Anti-Obesity Properties of the Dietary Green Alga, Codium cylindricum, in High-Fat Diet-Induced Obese Mice vol.64, pp.5, 2018, https://doi.org/10.3177/jnsv.64.347
  11. Phycochemical Constituents and Biological Activities of Fucus spp. vol.16, pp.8, 2018, https://doi.org/10.3390/md16080249
  12. Approaches for the sustainable production of fucoxanthin, a xanthophyll with potential health benefits pp.1573-5176, 2018, https://doi.org/10.1007/s10811-018-1558-3
  13. Brown Macroalgae as Valuable Food Ingredients vol.8, pp.9, 2019, https://doi.org/10.3390/antiox8090365
  14. Current Trends on Seaweeds: Looking at Chemical Composition, Phytopharmacology, and Cosmetic Applications vol.24, pp.22, 2013, https://doi.org/10.3390/molecules24224182
  15. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice vol.528, pp.2, 2013, https://doi.org/10.1016/j.bbrc.2020.05.050
  16. Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls vol.16, pp.2, 2013, https://doi.org/10.4103/1673-5374.290878
  17. Brown Algae Potential as a Functional Food against Hypercholesterolemia: Review vol.10, pp.2, 2013, https://doi.org/10.3390/foods10020234